FDA Seeks Simpler Registration Path for Distributed Drug Manufacturing
The U.S. Food and Drug Administration has proposed a rule to streamline registration for distributed manufacturing networks operating under a hub-and-spoke model and to clarify registration obligations for some foreign drug producers. The change would allow networks of equivalent manufacturing units overseen by a central quality hub to register as …